Adam Sinding Steensberg
Chief Executive Officer presso ZEALAND PHARMA A/S
Patrimonio netto: 4 M $ in data 31/03/2024
Profilo
Adam Sinding Steensberg is currently the President & Chief Executive Officer at Zealand Pharma A since 2022.
He is also currently serving as the Chief Executive Officer at The Danish Business Authority since 2019.
Additionally, he holds the position of Chairman at Cessatech A since 2021 and is an Independent Director at the same company since 2020.
Furthermore, he is a Director at Dansk Biotek.
In his former positions, Dr. Steensberg worked as a Medical Director at Novo Nordisk A, a Director at Beta Bionics, Inc., and as a Clinician at Rigshospitalet.
Dr. Steensberg obtained a doctorate degree from the University of Copenhagen.
He also holds an MBA from the International Institute for Management Development, which he received in 2015.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
ZEALAND PHARMA A/S
0.07% | 31/12/2023 | 41 143 ( 0.07% ) | 4 M $ | 31/03/2024 |
Posizioni attive di Adam Sinding Steensberg
| Società | Posizione | Inizio |
|---|---|---|
| ZEALAND PHARMA A/S | Chief Executive Officer | 30/03/2022 |
| CESSATECH A/S | Director/Board Member | 01/01/2020 |
| The Danish Business Authority | Chief Executive Officer | 01/03/2019 |
Dansk Biotek
 Dansk Biotek Miscellaneous Commercial ServicesCommercial Services Dansk Biotek is an industry association for biotech companies with promoting the biotechnological research, development and production in taking care of corporate interests in this regard, both nationally and internationally. The company was founded in 1987 and is headquartered in Copenhagen, Denmark. | Director/Board Member | - |
Precedenti posizioni note di Adam Sinding Steensberg
| Società | Posizione | Fine |
|---|---|---|
Rigshospitalet
 Rigshospitalet Hospital/Nursing ManagementHealth Services Rigshospitalet is a highly specialized hospital in Denmark that ensures all patients in Denmark have a treatment offer, no matter how rare or complicated their illness is. The hospital is located on Blegdamsvej and in Glostrup. Rigshospitalet prioritizes research and achieves and disseminates results through extensive national and international cooperation. The hospital has subsidiaries in Denmark. | Corporate Officer/Principal | - |
Beta Bionics, Inc.
 Beta Bionics, Inc. Medical SpecialtiesHealth Technology Beta Bionics, Inc. operates a medical technology company leveraging lifelong, machine-learning, artificial intelligence to develop and commercialize the autonomous bionic pancreas. The company was founded by Edward R. Damiano in October 21, 2015 and is headquartered in Boston, MA. | Director/Board Member | - |
| NOVO NORDISK A/S | Corporate Officer/Principal | - |
Formazione di Adam Sinding Steensberg
| University of Copenhagen | Doctorate Degree |
| International Institute for Management Development | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| ZEALAND PHARMA A/S | Health Technology |
| CESSATECH A/S | Health Technology |
| Aziende private | 4 |
|---|---|
Dansk Biotek
Dansk Biotek Miscellaneous Commercial ServicesCommercial Services Dansk Biotek is an industry association for biotech companies with promoting the biotechnological research, development and production in taking care of corporate interests in this regard, both nationally and internationally. The company was founded in 1987 and is headquartered in Copenhagen, Denmark. | Commercial Services |
Rigshospitalet
Rigshospitalet Hospital/Nursing ManagementHealth Services Rigshospitalet is a highly specialized hospital in Denmark that ensures all patients in Denmark have a treatment offer, no matter how rare or complicated their illness is. The hospital is located on Blegdamsvej and in Glostrup. Rigshospitalet prioritizes research and achieves and disseminates results through extensive national and international cooperation. The hospital has subsidiaries in Denmark. | Health Services |
Beta Bionics, Inc.
Beta Bionics, Inc. Medical SpecialtiesHealth Technology Beta Bionics, Inc. operates a medical technology company leveraging lifelong, machine-learning, artificial intelligence to develop and commercialize the autonomous bionic pancreas. The company was founded by Edward R. Damiano in October 21, 2015 and is headquartered in Boston, MA. | Health Technology |
| The Danish Business Authority | Government |
- Borsa valori
- Insiders
- Adam Sinding Steensberg
